Sort   by:  
 Page size 
UnknownPersistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies.
Not available
S-EPMC9805032 | biostudies-literature
UnknownCoagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial.
Not available
S-EPMC10825546 | biostudies-literature
UnknownCXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
Not available
S-EPMC9546500 | biostudies-literature
UnknownMulti-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan.
Not available
S-EPMC8444433 | biostudies-literature
UnknownRespiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
Not available
S-EPMC9115297 | biostudies-literature
UnknownNeutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial.
Not available
S-EPMC8447398 | biostudies-literature
UnknownEvaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Not available
S-EPMC8279143 | biostudies-literature
UnknownEffects of liberal versus restrictive transfusion strategies on intermittent hypoxaemia in extremely low birthweight infants: secondary analyses of the ETTNO randomised controlled trial.
Not available
S-EPMC12573360 | biostudies-literature
UnknownPersistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9.
Not available
S-EPMC8636497 | biostudies-literature
UnknownHigh Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19.
Not available
S-EPMC9384496 | biostudies-literature
Sort   by:  
 Page size